Menopause Market Size, Share & Trends Analysis Report By Treatment (Dietary Supplements, OTC Pharma Products), By Region (North America, Europe, APAC, Latin America, MEA), And Segment Forecasts, 2022 - 2030
This report can be delivered to the clients within 3 Business Days
Menopause Market Growth & Trends
The global menopause market size is expected to reach USD 24.4 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.29% from 2022 to 2030. Increasing awareness regarding menopause-associated health aspects, rising prevalence of post-menopausal syndrome, and high adoption of women’s health apps are expected to boost market growth during the forecast period. Key players in the region are conducting campaigns to create awareness about women’s health and the role of dietary supplements in easing the transition through it. For instance, in October 2021, Klassen, a reproductive mental health specialist, started the campaign, Let’s Talk Menopause, to make women aware of menopausal symptoms and treatment. The campaign started in 200 subway stations in New York and is its first-of-kind campaign in the U.S.
Rising research supporting the benefits of the dietary supplements than the HRT is projected to drive the market. There are various dietary supplements available in the market containing ingredients such as soy isoflavones, black cohosh, red clover, and amberen. Manufacturers are involved in the launch of new products for managing menopausal symptoms. For instance, in December 2021, Doctor’s Seaweed’s Weed and Wonderful, a U.K.-based food startup, launched seaweed-based supplements for menopause, which are organic and contain nutrients such as iodine and isoflavones.
The pandemic slowed down the market growth as the focus of pharmaceutical companies shifted towards the production of drugs and immune supplements for COVID-19. However, the demand for OTC pharma products and dietary supplements increased during the later phase of 2020 because of the postponement of hormonal replacement therapies, delays in physician’s appointments, and the easy availability of OTC drugs from online channels and retail pharmacies. The market is now stabilizing owing to the ease in the restrictions and the rising awareness regarding menopausal manifestation.
Menopause Market Report Highlights
Menopause Market Growth & Trends
The global menopause market size is expected to reach USD 24.4 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.29% from 2022 to 2030. Increasing awareness regarding menopause-associated health aspects, rising prevalence of post-menopausal syndrome, and high adoption of women’s health apps are expected to boost market growth during the forecast period. Key players in the region are conducting campaigns to create awareness about women’s health and the role of dietary supplements in easing the transition through it. For instance, in October 2021, Klassen, a reproductive mental health specialist, started the campaign, Let’s Talk Menopause, to make women aware of menopausal symptoms and treatment. The campaign started in 200 subway stations in New York and is its first-of-kind campaign in the U.S.
Rising research supporting the benefits of the dietary supplements than the HRT is projected to drive the market. There are various dietary supplements available in the market containing ingredients such as soy isoflavones, black cohosh, red clover, and amberen. Manufacturers are involved in the launch of new products for managing menopausal symptoms. For instance, in December 2021, Doctor’s Seaweed’s Weed and Wonderful, a U.K.-based food startup, launched seaweed-based supplements for menopause, which are organic and contain nutrients such as iodine and isoflavones.
The pandemic slowed down the market growth as the focus of pharmaceutical companies shifted towards the production of drugs and immune supplements for COVID-19. However, the demand for OTC pharma products and dietary supplements increased during the later phase of 2020 because of the postponement of hormonal replacement therapies, delays in physician’s appointments, and the easy availability of OTC drugs from online channels and retail pharmacies. The market is now stabilizing owing to the ease in the restrictions and the rising awareness regarding menopausal manifestation.
Menopause Market Report Highlights
- The dietary supplements treatment segment dominated the market in terms of revenue share in 2021 and is expected to witness the fastest growth during the forecast period. The factors contributing to segment growth are the rising geriatric population and the launch of innovative products. For instance, Pulmuone, a South-Korea based dietary supplement firm, launched a product containing soybean and hop extracts for the treatment of menopause-related symptoms
- The OTC pharma products treatment segment is divided into hormonal and non-hormonal products. Over-the-Counter (OTC) hormone preparations are becoming more common for use by women undergoing menopause. Some of the major products in the segment include Dehydroepiandrosterone (DHEA), ibuprofen, topical progesterone, and melatonin
- North America held the largest revenue share in 2021 due to factors such as the growing prevalence of menopausal symptoms. Moreover, an increase in awareness about dietary requirements is leading to a greater demand among older women
- Latin America is expected to register the fastest growth rate during the forecast period owing to factors such as rising awareness about women’s health and growing adoption of dietary supplements for menopausal symptoms
- In January 2022, Amyris entered into a definitive agreement for the acquisition of the MenoLabs LLC assets. MenoLabs is dedicated to providing products to improve menopause-related health issues
CHAPTER 1 METHODOLOGY AND SCOPE
1.1 Market Segmentation and Scope
1.1.1 regional scope
1.1.2 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information procurement
1.3.1 Purchased database
1.3.2 GVR’s internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.7 Research Assumptions
1.8 List of Secondary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective
1.10.2 Objective
1.10.3 Objective
1.10.4 Objective
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
2.2 Segment Outlook
2.2.1 Treatment
2.3 Regional Outlook
2.4 Competitive Insights
CHAPTER 3 MENOPAUSE MARKET VARIABLES, TRENDS, AND SCOPE
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2 Related/Ancillary Market Outlook
3.2 Penetration and Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market Driver Analysis
3.3.1.1 Growing number of women undergoing menopause
3.3.1.2 Increasing awareness about menopause and its treatment
3.3.1.3 Growing opportunities and innovations in menopause treatment
3.3.1.4 Increasing research supporting advantages of dietary supplements
3.3.2 Market Restraint Analysis
3.3.2.1 Social stigma associated with menopause and adverse effects of products
3.3.2.2 Lack of well-defined regulations
3.4 Qualitative Analysis Impact of COVID-19 on Menopause Market
3.5 List of products
3.6 Business Environment Analysis Tools
3.6.1 Porter’s five forces analysis
3.6.1.1 Threat of new entrants
3.6.1.2 Bargaining power of buyers
3.6.1.3 Threat of substitutes
3.6.1.4 Bargaining power of suppliers
3.6.1.5 Competitive rivalry
3.6.2 PESTLE analysis
3.6.2.1 Political and Legal
3.6.2.2 Economic
3.6.2.3 Social
3.6.2.4 Technological
CHAPTER 4 MENOPAUSE MARKET: SEGMENT ANALYSIS, BY TREATMENT, 2017 - 2030 (USD MILLION)
4.1 Menopause Treatment Market Share Analysis, 2021&2030
4.2 Menopause Treatment Market: Segment Dashboard
4.3 Market Size & Forecasts and Trend Analyses, 2017 - 2030 for the Treatment Segment
4.3.1 Dietary Supplements
4.3.1.1 Dietary Supplements Market, 2017 - 2030 (USD Million)
4.3.2 OTC Pharma Products
4.3.2.1 OTC Pharma Products Market, 2017 - 2030 (USD Million)
4.3.2.2 Hormonal Products
4.3.2.2.1 Hormonal Products Market, 2017 - 2030 (USD Million)
4.3.2.3 Non-hormonal Products
4.3.2.3.1 Non-Hormonal Products Market, 2017 - 2030 (USD Million)
CHAPTER 5 MENOPAUSE MARKET: REGIONAL MARKET ANALYSIS, 2017 - 2030 (USD MILLION)
5.1 Menopause Regional Market Share Analysis, 2021&2030
5.2 Regional Market Snapshot
5.3 Market Size, & Forecasts, Trend Analysis, 2021 to 2030
5.3.1 North America
5.3.1.1 North America Menopause Market, 2017 - 2030 (USD Million)
5.3.1.2 U.S.
5.3.1.2.1 U.S. Menopause Market, 2017 - 2030 (USD Million)
5.3.1.3 Canada
5.3.1.3.1 Canada Menopause Market, 2017 - 2030 (USD Million)
5.3.2 Europe
5.3.2.1 Europe Menopause Market, 2017 - 2030 (USD Million)
5.3.2.2 U.K.
5.3.2.2.1 U.K. Menopause Market, 2017 - 2030 (USD Million)
5.3.2.3 Germany
5.3.2.3.1 Germany Menopause Market, 2017 - 2030 (USD Million)
5.3.2.4 France
5.3.2.4.1 France Menopause Market, 2017 - 2030 (USD Million)
5.3.2.5 Italy
5.3.2.5.1 Italy Menopause Market, 2017 - 2030 (USD Million)
5.3.2.6 Spain
5.3.2.6.1 Spain Menopause Market, 2017 - 2030 (USD Million)
5.3.2.7 Austria
5.3.2.7.1 Austria Menopause Market, 2017 - 2030 (USD Million)
5.3.3 Asia Pacific
5.3.3.1 Asia Pacific Menopause Market, 2017 - 2030 (USD Million)
5.3.3.2 Japan
5.3.3.2.1 Japan Menopause Market, 2017 - 2030 (USD Million)
5.3.3.3 China
5.3.3.3.1 China Menopause Market, 2017 - 2030 (USD Million)
5.3.3.4 India
5.3.3.4.1 India Menopause Market, 2017 - 2030 (USD Million)
5.3.3.5 South Korea
5.3.3.5.1 South Korea Menopause Market, 2017 - 2030 (USD Million)
5.3.4 Latin America
5.3.4.1 Latin America Menopause Market, 2017 - 2030 (USD Million)
5.3.4.2 Mexico
5.3.4.2.1 Mexico Menopause Market, 2017 - 2030 (USD Million)
5.3.4.3 Brazil
5.3.4.3.1 Brazil Menopause Market, 2017 - 2030 (USD Million)
5.3.5 Middle East & Africa
5.3.5.1 Middle East & Africa Menopause Market, 2017 - 2030 (USD Million)
5.3.5.2 South Africa
5.3.5.2.1 South Africa Menopause Market, 2017 - 2030 (USD Million)
CHAPTER 6 MENOPAUSE MARKET: COMPETITIVE LANDSCAPE
6.1 Recent developments & impact analysis, by key market participants
6.2 Company Categorization
6.3 Company Market Position Analysis
6.4 Company Profiles
6.4.1 Bayer AG
6.4.1.1 Company overview
6.4.1.2 Financial performance
6.4.1.3 Product benchmarking
6.4.1.4 Strategic initiatives
6.4.2 Theramex
6.4.2.1 Company overview
6.4.2.2 Financial performance
6.4.2.3 Product benchmarking
6.4.2.4 Strategic initiatives
6.4.3 Abbvie Inc.
6.4.3.1 Company overview
6.4.3.2 Financial performance
6.4.3.3 Product benchmarking
6.4.3.4 Strategic initiatives
6.4.4 Abbott
6.4.4.1 Company overview
6.4.4.2 Financial performance
6.4.4.3 Product benchmarking
6.4.4.4 Strategic initiatives
6.5.5 Pure Encapsulations, LLC
6.5.5.1 Company overview
6.5.5.2 Financial performance
6.5.5.3 Product benchmarking
6.5.5.4 Strategic initiatives
6.5.6 Dr. Reddy’s Laboratories Ltd.
6.5.6.1 Company overview
6.5.6.2 Financial performance
6.5.6.3 Product benchmarking
6.5.6.4 Strategic initiatives
6.5.7 Rainbow Light
6.5.7.1 Company overview
6.5.7.2 Financial performance
6.5.7.3 Product benchmarking
6.5.7.4 Strategic initiatives
6.5.8 PADAGIS LLC
6.5.8.1 Company overview
6.5.8.2 Financial performance
6.5.8.3 Product benchmarking
6.5.8.4 Strategic initiatives
1.1 Market Segmentation and Scope
1.1.1 regional scope
1.1.2 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information procurement
1.3.1 Purchased database
1.3.2 GVR’s internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.7 Research Assumptions
1.8 List of Secondary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective
1.10.2 Objective
1.10.3 Objective
1.10.4 Objective
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
2.2 Segment Outlook
2.2.1 Treatment
2.3 Regional Outlook
2.4 Competitive Insights
CHAPTER 3 MENOPAUSE MARKET VARIABLES, TRENDS, AND SCOPE
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2 Related/Ancillary Market Outlook
3.2 Penetration and Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market Driver Analysis
3.3.1.1 Growing number of women undergoing menopause
3.3.1.2 Increasing awareness about menopause and its treatment
3.3.1.3 Growing opportunities and innovations in menopause treatment
3.3.1.4 Increasing research supporting advantages of dietary supplements
3.3.2 Market Restraint Analysis
3.3.2.1 Social stigma associated with menopause and adverse effects of products
3.3.2.2 Lack of well-defined regulations
3.4 Qualitative Analysis Impact of COVID-19 on Menopause Market
3.5 List of products
3.6 Business Environment Analysis Tools
3.6.1 Porter’s five forces analysis
3.6.1.1 Threat of new entrants
3.6.1.2 Bargaining power of buyers
3.6.1.3 Threat of substitutes
3.6.1.4 Bargaining power of suppliers
3.6.1.5 Competitive rivalry
3.6.2 PESTLE analysis
3.6.2.1 Political and Legal
3.6.2.2 Economic
3.6.2.3 Social
3.6.2.4 Technological
CHAPTER 4 MENOPAUSE MARKET: SEGMENT ANALYSIS, BY TREATMENT, 2017 - 2030 (USD MILLION)
4.1 Menopause Treatment Market Share Analysis, 2021&2030
4.2 Menopause Treatment Market: Segment Dashboard
4.3 Market Size & Forecasts and Trend Analyses, 2017 - 2030 for the Treatment Segment
4.3.1 Dietary Supplements
4.3.1.1 Dietary Supplements Market, 2017 - 2030 (USD Million)
4.3.2 OTC Pharma Products
4.3.2.1 OTC Pharma Products Market, 2017 - 2030 (USD Million)
4.3.2.2 Hormonal Products
4.3.2.2.1 Hormonal Products Market, 2017 - 2030 (USD Million)
4.3.2.3 Non-hormonal Products
4.3.2.3.1 Non-Hormonal Products Market, 2017 - 2030 (USD Million)
CHAPTER 5 MENOPAUSE MARKET: REGIONAL MARKET ANALYSIS, 2017 - 2030 (USD MILLION)
5.1 Menopause Regional Market Share Analysis, 2021&2030
5.2 Regional Market Snapshot
5.3 Market Size, & Forecasts, Trend Analysis, 2021 to 2030
5.3.1 North America
5.3.1.1 North America Menopause Market, 2017 - 2030 (USD Million)
5.3.1.2 U.S.
5.3.1.2.1 U.S. Menopause Market, 2017 - 2030 (USD Million)
5.3.1.3 Canada
5.3.1.3.1 Canada Menopause Market, 2017 - 2030 (USD Million)
5.3.2 Europe
5.3.2.1 Europe Menopause Market, 2017 - 2030 (USD Million)
5.3.2.2 U.K.
5.3.2.2.1 U.K. Menopause Market, 2017 - 2030 (USD Million)
5.3.2.3 Germany
5.3.2.3.1 Germany Menopause Market, 2017 - 2030 (USD Million)
5.3.2.4 France
5.3.2.4.1 France Menopause Market, 2017 - 2030 (USD Million)
5.3.2.5 Italy
5.3.2.5.1 Italy Menopause Market, 2017 - 2030 (USD Million)
5.3.2.6 Spain
5.3.2.6.1 Spain Menopause Market, 2017 - 2030 (USD Million)
5.3.2.7 Austria
5.3.2.7.1 Austria Menopause Market, 2017 - 2030 (USD Million)
5.3.3 Asia Pacific
5.3.3.1 Asia Pacific Menopause Market, 2017 - 2030 (USD Million)
5.3.3.2 Japan
5.3.3.2.1 Japan Menopause Market, 2017 - 2030 (USD Million)
5.3.3.3 China
5.3.3.3.1 China Menopause Market, 2017 - 2030 (USD Million)
5.3.3.4 India
5.3.3.4.1 India Menopause Market, 2017 - 2030 (USD Million)
5.3.3.5 South Korea
5.3.3.5.1 South Korea Menopause Market, 2017 - 2030 (USD Million)
5.3.4 Latin America
5.3.4.1 Latin America Menopause Market, 2017 - 2030 (USD Million)
5.3.4.2 Mexico
5.3.4.2.1 Mexico Menopause Market, 2017 - 2030 (USD Million)
5.3.4.3 Brazil
5.3.4.3.1 Brazil Menopause Market, 2017 - 2030 (USD Million)
5.3.5 Middle East & Africa
5.3.5.1 Middle East & Africa Menopause Market, 2017 - 2030 (USD Million)
5.3.5.2 South Africa
5.3.5.2.1 South Africa Menopause Market, 2017 - 2030 (USD Million)
CHAPTER 6 MENOPAUSE MARKET: COMPETITIVE LANDSCAPE
6.1 Recent developments & impact analysis, by key market participants
6.2 Company Categorization
6.3 Company Market Position Analysis
6.4 Company Profiles
6.4.1 Bayer AG
6.4.1.1 Company overview
6.4.1.2 Financial performance
6.4.1.3 Product benchmarking
6.4.1.4 Strategic initiatives
6.4.2 Theramex
6.4.2.1 Company overview
6.4.2.2 Financial performance
6.4.2.3 Product benchmarking
6.4.2.4 Strategic initiatives
6.4.3 Abbvie Inc.
6.4.3.1 Company overview
6.4.3.2 Financial performance
6.4.3.3 Product benchmarking
6.4.3.4 Strategic initiatives
6.4.4 Abbott
6.4.4.1 Company overview
6.4.4.2 Financial performance
6.4.4.3 Product benchmarking
6.4.4.4 Strategic initiatives
6.5.5 Pure Encapsulations, LLC
6.5.5.1 Company overview
6.5.5.2 Financial performance
6.5.5.3 Product benchmarking
6.5.5.4 Strategic initiatives
6.5.6 Dr. Reddy’s Laboratories Ltd.
6.5.6.1 Company overview
6.5.6.2 Financial performance
6.5.6.3 Product benchmarking
6.5.6.4 Strategic initiatives
6.5.7 Rainbow Light
6.5.7.1 Company overview
6.5.7.2 Financial performance
6.5.7.3 Product benchmarking
6.5.7.4 Strategic initiatives
6.5.8 PADAGIS LLC
6.5.8.1 Company overview
6.5.8.2 Financial performance
6.5.8.3 Product benchmarking
6.5.8.4 Strategic initiatives
LIST OF TABLES
TABLE 1 List of secondary sources
TABLE 2 List of abbreviation
TABLE 3 Global dietary supplements market estimates and forecast, 2017 - 2030 (USD Million)
TABLE 4 Global OTC pharma products market estimates and forecast, 2017 - 2030 (USD Million)
TABLE 5 North America menopause market estimates and forecast, 2017 - 2030 (USD Million)
TABLE 6 North America menopause market revenue estimates and forecast by treatment, 2017 - 2030 (USD Million)
TABLE 7 U.S. menopause market estimates and forecast, 2017 - 2030 (USD Million)
TABLE 8 U.S. menopause market revenue estimates and forecast by treatment, 2017 – 2030 (USD Million)
TABLE 9 Canada menopause market estimates and forecast, 2017 - 2030 (USD Million)
TABLE 10 Canada menopause market revenue estimates and forecast by treatment, 2017 - 2030 (USD Million)
TABLE 11 Europe menopause market estimates and forecast, 2017 - 2030 (USD Million)
TABLE 12 Europe menopause market revenue estimates and forecast by treatment, 2017 - 2030 (USD Million)
TABLE 13 U.K. menopause market estimates and forecast, 2017 - 2030 (USD Million)
TABLE 14 U.K. menopause market revenue estimates and forecast by treatment, 2017 - 2030 (USD Million)
TABLE 15 Germany menopause market estimates and forecast, 2017 - 2030 (USD Million)
TABLE 16 Germany menopause market revenue estimates and forecast by treatment, 2017 - 2030 (USD Million)
TABLE 17 France menopause market estimates and forecast, 2017 - 2030 (USD Million)
TABLE 18 France menopause market revenue estimates and forecast by treatment, 2017 - 2030 (USD Million)
TABLE 19 Italy menopause market estimates and forecast, 2017 - 2030 (USD Million)
TABLE 20 Italy menopause market revenue estimates and forecast by treatment, 2017 - 2030 (USD Million)
TABLE 21 Spain menopause market estimates and forecast, 2017 - 2030 (USD Million)
TABLE 22 Spain menopause market revenue estimates and forecast by treatment, 2017 - 2030 (USD Million)
TABLE 23 Austria menopause market estimates and forecast, 2017 - 2030 (USD Million)
TABLE 24 Austria menopause market revenue estimates and forecast by treatment, 2017 - 2030 (USD Million)
TABLE 25 Asia Pacific menopause market estimates and forecast, 2017 - 2030 (USD Million)
TABLE 26 Asia Pacific menopause market revenue estimates and forecast by treatment, 2017 - 2030 (USD Million)
TABLE 27 China menopause market estimates and forecast, 2017 - 2030 (USD Million)
TABLE 28 China menopause market revenue estimates and forecast by treatment, 2017 - 2030 (USD Million)
TABLE 29 Japan menopause market estimates and forecast, 2017 - 2030 (USD Million)
TABLE 30 Japan menopause market revenue estimates and forecast by treatment, 2017 - 2030 (USD Million)
TABLE 31 India menopause market estimates and forecast, 2017 - 2030 (USD Million)
TABLE 32 India menopause market revenue estimates and forecast by treatment, 2017 - 2030 (USD Million)
TABLE 33 South Korea menopause market estimates and forecast, 2017 - 2030 (USD Million)
TABLE 34 South Korea menopause market revenue estimates and forecast by treatment, 2017 - 2030 (USD Million)
TABLE 35 Latin America menopause market estimates and forecast, 2017 - 2030 (USD Million)
TABLE 36 Latin America menopause market revenue estimates and forecast by treatment, 2017 - 2030 (USD Million)
TABLE 37 Brazil menopause market estimates and forecast, 2017 - 2030 (USD Million)
TABLE 38 Brazil menopause market revenue estimates and forecast by treatment, 2017 - 2030 (USD Million)
TABLE 39 Mexico menopause market estimates and forecast, 2017 - 2030 (USD Million)
TABLE 40 Mexico menopause market revenue estimates and forecast by treatment, 2017 - 2030 (USD Million)
TABLE 41 Middle East & Africa (MEA) menopause market estimates and forecast, 2017 - 2030 (USD Million)
TABLE 42 Middle East & Africa (MEA) menopause market revenue estimates and forecast by treatment, 2017 - 2030 (USD Million)
TABLE 43 South Africa menopause market estimates and forecast, 2017 - 2030 (USD Million)
TABLE 44 South Africa menopause market revenue estimates and forecast by treatment, 2017 - 2030 (USD Million)
TABLE 1 List of secondary sources
TABLE 2 List of abbreviation
TABLE 3 Global dietary supplements market estimates and forecast, 2017 - 2030 (USD Million)
TABLE 4 Global OTC pharma products market estimates and forecast, 2017 - 2030 (USD Million)
TABLE 5 North America menopause market estimates and forecast, 2017 - 2030 (USD Million)
TABLE 6 North America menopause market revenue estimates and forecast by treatment, 2017 - 2030 (USD Million)
TABLE 7 U.S. menopause market estimates and forecast, 2017 - 2030 (USD Million)
TABLE 8 U.S. menopause market revenue estimates and forecast by treatment, 2017 – 2030 (USD Million)
TABLE 9 Canada menopause market estimates and forecast, 2017 - 2030 (USD Million)
TABLE 10 Canada menopause market revenue estimates and forecast by treatment, 2017 - 2030 (USD Million)
TABLE 11 Europe menopause market estimates and forecast, 2017 - 2030 (USD Million)
TABLE 12 Europe menopause market revenue estimates and forecast by treatment, 2017 - 2030 (USD Million)
TABLE 13 U.K. menopause market estimates and forecast, 2017 - 2030 (USD Million)
TABLE 14 U.K. menopause market revenue estimates and forecast by treatment, 2017 - 2030 (USD Million)
TABLE 15 Germany menopause market estimates and forecast, 2017 - 2030 (USD Million)
TABLE 16 Germany menopause market revenue estimates and forecast by treatment, 2017 - 2030 (USD Million)
TABLE 17 France menopause market estimates and forecast, 2017 - 2030 (USD Million)
TABLE 18 France menopause market revenue estimates and forecast by treatment, 2017 - 2030 (USD Million)
TABLE 19 Italy menopause market estimates and forecast, 2017 - 2030 (USD Million)
TABLE 20 Italy menopause market revenue estimates and forecast by treatment, 2017 - 2030 (USD Million)
TABLE 21 Spain menopause market estimates and forecast, 2017 - 2030 (USD Million)
TABLE 22 Spain menopause market revenue estimates and forecast by treatment, 2017 - 2030 (USD Million)
TABLE 23 Austria menopause market estimates and forecast, 2017 - 2030 (USD Million)
TABLE 24 Austria menopause market revenue estimates and forecast by treatment, 2017 - 2030 (USD Million)
TABLE 25 Asia Pacific menopause market estimates and forecast, 2017 - 2030 (USD Million)
TABLE 26 Asia Pacific menopause market revenue estimates and forecast by treatment, 2017 - 2030 (USD Million)
TABLE 27 China menopause market estimates and forecast, 2017 - 2030 (USD Million)
TABLE 28 China menopause market revenue estimates and forecast by treatment, 2017 - 2030 (USD Million)
TABLE 29 Japan menopause market estimates and forecast, 2017 - 2030 (USD Million)
TABLE 30 Japan menopause market revenue estimates and forecast by treatment, 2017 - 2030 (USD Million)
TABLE 31 India menopause market estimates and forecast, 2017 - 2030 (USD Million)
TABLE 32 India menopause market revenue estimates and forecast by treatment, 2017 - 2030 (USD Million)
TABLE 33 South Korea menopause market estimates and forecast, 2017 - 2030 (USD Million)
TABLE 34 South Korea menopause market revenue estimates and forecast by treatment, 2017 - 2030 (USD Million)
TABLE 35 Latin America menopause market estimates and forecast, 2017 - 2030 (USD Million)
TABLE 36 Latin America menopause market revenue estimates and forecast by treatment, 2017 - 2030 (USD Million)
TABLE 37 Brazil menopause market estimates and forecast, 2017 - 2030 (USD Million)
TABLE 38 Brazil menopause market revenue estimates and forecast by treatment, 2017 - 2030 (USD Million)
TABLE 39 Mexico menopause market estimates and forecast, 2017 - 2030 (USD Million)
TABLE 40 Mexico menopause market revenue estimates and forecast by treatment, 2017 - 2030 (USD Million)
TABLE 41 Middle East & Africa (MEA) menopause market estimates and forecast, 2017 - 2030 (USD Million)
TABLE 42 Middle East & Africa (MEA) menopause market revenue estimates and forecast by treatment, 2017 - 2030 (USD Million)
TABLE 43 South Africa menopause market estimates and forecast, 2017 - 2030 (USD Million)
TABLE 44 South Africa menopause market revenue estimates and forecast by treatment, 2017 - 2030 (USD Million)
LIST OF FIGURES
FIG. 1 Menopause market segmentation
FIG. 2 Market research process
FIG. 3 Information procurement
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value-chain-based sizing & forecasting
FIG. 7 QFD modeling for market share assessment
FIG. 8 Market formulation & validation
FIG. 9 Menopause market outlook 2021 (USD Million)
FIG. 10 Penetration & growth prospect mapping
FIG. 11 Market driver relevance analysis (Current & future impact)
FIG. 12 Market restraint relevance analysis (Current & future impact)
FIG. 13 Menopause market: Treatment movement analysis
FIG. 14 Menopause market treatment outlook: Key takeaways
FIG. 15 Dietary supplements market, 2017 - 2030 (USD Million)
FIG. 16 OTC pharma products market, 2017 - 2030 (USD Million)
FIG. 17 Hormonal products market, 2017 - 2030 (USD Million)
FIG. 18 Non-hormonal products market, 2017 - 2030 (USD Million)
FIG. 19 Regional outlook, 2021&2030
FIG. 20 Regional market dashboard
FIG. 21 Regional market place: Key takeaways
FIG. 22 North America dietary supplements market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 23 North America OTC pharma products market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 24 U.S. dietary supplements market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 25 U.S. OTC pharma products market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 26 Canada dietary supplements market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 27 Canada OTC pharma products market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 28 Europe dietary supplements market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 29 Europe OTC pharma products market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 30 U.K. dietary supplements market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 31 U.K. OTC pharma products market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 32 Germany dietary supplements market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 33 Germany OTC pharma products market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 34 Spain dietary supplements market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 35 Spain OTC pharma products market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 36 France dietary supplements market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 37 France OTC pharma products market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 34 Italy dietary supplements market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 39 Italy OTC pharma products market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 40 Austria dietary supplements market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 42 Austria OTC pharma products market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 43 Asia Pacific dietary supplements market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 44 Asia Pacific OTC pharma products market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 45 Japan dietary supplements market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 46 Japan OTC pharma products market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 47 China dietary supplements market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 48 China OTC pharma products market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 49 India dietary supplements market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 50 India OTC pharma products market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 51 South Korea dietary supplements market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 52 South Korea OTC pharma products market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 53 Latin dietary supplements market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 54 Latin America OTC pharma products market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 55 Brazil dietary supplements market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 56 Brazil OTC pharma products market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 57 Mexico dietary supplements market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 58 Mexico OTC pharma products market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 59 MEA dietary supplements market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 60 MEA OTC pharma products market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 61 South Africa dietary supplements market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 62 South Africa OTC pharma products market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 63 Impact analysis by key market participants
FIG. 64 Strategy framework/ Competition categorization
FIG. 65 Company market position analysis
FIG. 1 Menopause market segmentation
FIG. 2 Market research process
FIG. 3 Information procurement
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value-chain-based sizing & forecasting
FIG. 7 QFD modeling for market share assessment
FIG. 8 Market formulation & validation
FIG. 9 Menopause market outlook 2021 (USD Million)
FIG. 10 Penetration & growth prospect mapping
FIG. 11 Market driver relevance analysis (Current & future impact)
FIG. 12 Market restraint relevance analysis (Current & future impact)
FIG. 13 Menopause market: Treatment movement analysis
FIG. 14 Menopause market treatment outlook: Key takeaways
FIG. 15 Dietary supplements market, 2017 - 2030 (USD Million)
FIG. 16 OTC pharma products market, 2017 - 2030 (USD Million)
FIG. 17 Hormonal products market, 2017 - 2030 (USD Million)
FIG. 18 Non-hormonal products market, 2017 - 2030 (USD Million)
FIG. 19 Regional outlook, 2021&2030
FIG. 20 Regional market dashboard
FIG. 21 Regional market place: Key takeaways
FIG. 22 North America dietary supplements market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 23 North America OTC pharma products market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 24 U.S. dietary supplements market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 25 U.S. OTC pharma products market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 26 Canada dietary supplements market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 27 Canada OTC pharma products market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 28 Europe dietary supplements market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 29 Europe OTC pharma products market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 30 U.K. dietary supplements market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 31 U.K. OTC pharma products market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 32 Germany dietary supplements market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 33 Germany OTC pharma products market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 34 Spain dietary supplements market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 35 Spain OTC pharma products market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 36 France dietary supplements market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 37 France OTC pharma products market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 34 Italy dietary supplements market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 39 Italy OTC pharma products market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 40 Austria dietary supplements market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 42 Austria OTC pharma products market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 43 Asia Pacific dietary supplements market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 44 Asia Pacific OTC pharma products market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 45 Japan dietary supplements market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 46 Japan OTC pharma products market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 47 China dietary supplements market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 48 China OTC pharma products market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 49 India dietary supplements market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 50 India OTC pharma products market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 51 South Korea dietary supplements market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 52 South Korea OTC pharma products market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 53 Latin dietary supplements market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 54 Latin America OTC pharma products market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 55 Brazil dietary supplements market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 56 Brazil OTC pharma products market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 57 Mexico dietary supplements market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 58 Mexico OTC pharma products market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 59 MEA dietary supplements market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 60 MEA OTC pharma products market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 61 South Africa dietary supplements market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 62 South Africa OTC pharma products market estimates and forecast, 2017 - 2030 (USD Million)
FIG. 63 Impact analysis by key market participants
FIG. 64 Strategy framework/ Competition categorization
FIG. 65 Company market position analysis
